NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the NAPLEX exam with a comprehensive quiz featuring multiple-choice questions and in-depth explanations. Build your pharmacological knowledge and increase your chances of passing the pharmacist licensure examination!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


Which Anti-TNF Biologic DMARD is administered SC weekly?

  1. Adalimumab: Humira

  2. Certolizumab: Cimzia

  3. Etanercept: Enbrel

  4. Infliximab: Remicade

The correct answer is: Etanercept: Enbrel

Etanercept (Enbrel) is the anti-TNF biologic DMARD that is administered subcutaneously weekly. It differs from the other options as Adalimumab (Humira) is usually given every other week, Certolizumab (Cimzia) is administered subcutaneously every 2-4 weeks, and Infliximab (Remicade) is typically given via intravenous infusion. Therefore, the correct answer is C.